Covered recipient · General Payments record
AZRA HAKIMI
Allopathic & Osteopathic Physicians Pediatrics
General Payments · PY2021–2024
$955.95
- Reported across 46 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $375.70 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Corium, Inc. | $151.24 | 11 |
| ALK-Abello, Inc | $127.69 | 2 |
| GlaxoSmithKline, LLC. | $29.00 | 2 |
| Acerta Pharma LLC | $27.71 | 1 |
| PFIZER INC. | $20.30 | 1 |
| Cranial Technologies, Inc | $19.76 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ALK-Abello, Inc | $108.42 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099891271 | CMS |
| ALK-Abello, Inc | $19.27 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099891269 | CMS |
| AstraZeneca Pharmaceuticals LP | $27.71 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105383944 | CMS |
| Corium, LLC | $16.17 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100109768 | CMS |
| Corium, LLC | $3.89 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100134242 | CMS |
| Corium, LLC | $23.27 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100087780 | CMS |
| Corium, LLC | $5.00 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100132698 | CMS |
| Corium, LLC | $16.15 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100109832 | CMS |
| Corium, LLC | $4.37 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100144310 | CMS |
| Corium, LLC | $24.48 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100190353 | CMS |
| Corium, LLC | $4.37 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100144316 | CMS |
| Corium, LLC | $24.61 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100190627 | CMS |
| Corium, LLC | $4.67 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100144732 | CMS |
| Corium, LLC | $24.26 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100189845 | CMS |
| Cranial Technologies, Inc | $19.76 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082217612 | CMS |
| GlaxoSmithKline, LLC. | $13.35 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116409345 | CMS |
| GlaxoSmithKline, LLC. | $15.65 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116482571 | CMS |
| PFIZER INC. | $20.30 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131064037 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.